Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT02656628




Registration number
NCT02656628
Ethics application status
Date submitted
4/07/2014
Date registered
15/01/2016
Date last updated
21/01/2016

Titles & IDs
Public title
Observational Patient Registry of the Dynamic Locking Screws
Scientific title
A Multi-Center Prospective, Observational Patient Registry of the Dynamic Locking Screws in Metaphyseal and Diaphyseal Shaft Fractures of the Humerus, Femur and Tibia
Secondary ID [1] 0 0
STU-TRA-T-08-198-03
Universal Trial Number (UTN)
Trial acronym
DLS
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Proximal or Diaphyseal Humerus Fracture 0 0
Diaphyseal or Distal Femur Fracture 0 0
Diaphyseal, Distal or Proximal Tibia Fracture 0 0
Condition category
Condition code
Injuries and Accidents 0 0 0 0
Fractures
Musculoskeletal 0 0 0 0
Other muscular and skeletal disorders

Intervention/exposure
Study type
Observational [Patient Registry]
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Treatment: Devices - Dynamic Locking Screw 3.7mm and 5.0mm

Fractures of humerus femur tibia - Dynamic Locking Screw 3.7mm and 5.0mm


Treatment: Devices: Dynamic Locking Screw 3.7mm and 5.0mm
Treatment with DLS and locked plate constructs (small or large fragments)
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Radiographic callus formation and location of callus evaluation: Change over time
Timepoint [1] 0 0
6 weeks, 12 weeks, 6 months, and (12)* months
Secondary outcome [1] 0 0
Fracture union
Timepoint [1] 0 0
6 weeks, 12 weeks, 6 months, and (12)* months
Secondary outcome [2] 0 0
QuickDASH for patients with humerus fracture
Timepoint [2] 0 0
Time point: 6 and 12 weeks, 6 and (12)* months
Secondary outcome [3] 0 0
WOMAC for patients with femur and tibia fractures
Timepoint [3] 0 0
Time point: 6 and 12 weeks, 6 and (12)* months
Secondary outcome [4] 0 0
Full weight bearing or full use of the upper extremity
Timepoint [4] 0 0
6 and 12 weeks, 6 and (12)* months
Secondary outcome [5] 0 0
Adverse Events related to the device or procedure
Timepoint [5] 0 0
intra-and postoperative; 6 and 12 weeks; 6 and (12)* months
Secondary outcome [6] 0 0
General adverse events not related to the device or procedure
Timepoint [6] 0 0
postoperative; 6 and 12 weeks; 6 and (12)* months
Secondary outcome [7] 0 0
Secondary surgical interventions due to device or procedure related Adverse events
Timepoint [7] 0 0
postoperative; 6 and 12 weeks; 6 and (12)* months
Secondary outcome [8] 0 0
Health related quality of life: EuroQoL (EQ-5D)
Timepoint [8] 0 0
Baseline; 6 and 12 weeks; 6 and (12)* months

Eligibility
Key inclusion criteria
* Age: =18 years
* Any of the following fracture types:

* Proximal or diaphyseal humerus fracture
* Diaphyseal or distal femur fracture
* Diaphyseal, distal or proximal tibia fracture
* Eligible for treatment with Synthes DLS and locked plate constructs (small or large fragments)
* Patients able and willing to sign informed consent form
* Patients able and willing to adhere to 12-months follow-up visits
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Polytrauma
* Pregnant or nursing females
* Patients already participating in an investigational trial
* Patients who are not expected to survive the follow-up period

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Withdrawn
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
1/05/2015
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/11/2016
Actual
Sample size
Target
Accrual to date
Final
0
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 0 0
Princess Alexandra Hospital - Woolloongabba, Brisbane
Recruitment postcode(s) [1] 0 0
4102 - Woolloongabba, Brisbane

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Synthes GmbH
Address
Country
Other collaborator category [1] 0 0
Commercial sector/industry
Name [1] 0 0
Synthes Australia Pty Ltd
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT02656628